INFLARX NV's ticker is IFRX and the CUSIP is N44821101. A total of 27 filers reported holding INFLARX NV in Q1 2020. The put-call ratio across all filers is - and the average weighting 0.1%.
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Bain Capital Life Sciences Investors, LLC | 1,764,888 | $60,571,000 | 13.75% |
| RA Capital Management | 1,967,848 | $67,537,000 | 3.61% |
| Cormorant Asset Management, LP | 1,341,540 | $46,042,000 | 2.99% |
| Redmile Group, LLC | 2,024,900 | $69,495,000 | 2.14% |
| EMORY UNIVERSITY | 90,437 | $3,104,000 | 2.03% |
| Artal Group S.A. | 500,000 | $17,160,000 | 0.45% |
| Birchview Capital, LP | 16,000 | $549,000 | 0.35% |
| Eventide Asset Management | 275,000 | $9,438,000 | 0.35% |
| Rock Springs Capital Management LP | 177,500 | $6,092,000 | 0.22% |
| ADAGE CAPITAL PARTNERS GP, L.L.C. | 2,551,959 | $87,583,000 | 0.20% |